Olutasidenib as maintenance therapy after treatment response in acute myeloid leukemia with persistent IDH1 mutation
- Author(s)
- Jonas, BA; Seiter, K; Wei, AH; Wang, ES; Wang, S; Sheppard, AD; De Botton, S;
- Details
- Publication Year 2026-08,Volume 3,Issue #3,Page 100226
- Journal Title
- Blood Neoplasia
- Research Division(s)
- Blood Cells and Blood Cancer
- PubMed ID
- 42221837
- Publisher's Version
- https://doi.org/10.1016/j.bneo.2026.100226
- Open Access at Publisher's Site
https://doi.org/10.1016/j.bneo.2026.100226- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-06-10 01:51:13
Last Modified: 2026-06-10 01:55:06